1. Home
  2. BOX vs OGN Comparison

BOX vs OGN Comparison

Compare BOX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

HOLD

Current Price

$24.18

Market Cap

3.4B

Sector

Technology

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.06

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
OGN
Founded
2005
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
1.5B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
BOX
OGN
Price
$24.18
$6.06
Analyst Decision
Buy
Hold
Analyst Count
8
4
Target Price
$35.57
$11.75
AVG Volume (30 Days)
2.1M
3.2M
Earning Date
05-26-2026
04-30-2026
Dividend Yield
N/A
1.26%
EPS Growth
N/A
N/A
EPS
0.58
0.72
Revenue
$506,142,000.00
$6,216,000,000.00
Revenue This Year
$9.41
$0.42
Revenue Next Year
$8.15
$1.67
P/E Ratio
$41.41
$8.83
Revenue Growth
26.98
N/A
52 Week Low
$21.61
$5.69
52 Week High
$38.80
$13.25

Technical Indicators

Market Signals
Indicator
BOX
OGN
Relative Strength Index (RSI) 50.59 39.81
Support Level $23.29 N/A
Resistance Level $33.30 $7.87
Average True Range (ATR) 0.78 0.27
MACD 0.02 0.06
Stochastic Oscillator 63.66 41.55

Price Performance

Historical Comparison
BOX
OGN

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: